𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab

✍ Scribed by Keisuke Ojiro; Makoto Naganuma; Hirotoshi Ebinuma; Hiroyoshi Kunimoto; Shinichiro Tada; Haruhiko Ogata; Yasushi Iwao; Hidetsugu Saito; Toshifumi Hibi

Publisher
Springer Japan
Year
2008
Tongue
English
Weight
305 KB
Volume
43
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamivudine resistance and exacerbation o
Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn's disease patient
✍ Maria Esteve; Carme Loras; Ferran González-Huix 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

2004 we reported 3 cases of chronic hepatitis B in Crohn's disease (CD) patients from a cohort of 80 patients treated with infliximab. 1 Two patients showed severe reactivation, 1 of whom died. Based on the American Association for the Study of Liver Disease (AASLD) and European guidelines, 2,3 pree

Splenic function and IgM-memory B cells
Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab
✍ Antonio Di Sabatino; M. Manuela Rosado; Paolo Cazzola; Paolo Biancheri; Francesc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB 👁 2 views

Background: Under experimental chronic inflammation, tumor necrosis factor (TNF)-␣ plays a role in damaging spleen marginal zone. This latter has a crucial function in mounting B cell-dependent immune responses against infections by encapsulated bacteria. In Crohn's disease (CD), a chronic inflammat